REFERENCES
1.Pallan S, Rahman MO, Khan AA. Diagnosis and management of primary hyperparathyroidism. BMJ. 2012; 344: e1013.
2. M.D. Walker and S.J. Silverberg Cardiovascular aspects of primary hyperparathyroidism J Endocrinol Invest. 2008 October; 31(10): 925–931.
3. January CT, Wann LS, Alpert JS, et al: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the american college of cardiology/american heart association task force on practice guidelines and the heart rhythm society. Journal of the American College of Cardiology. 2014;64: e1-76.
4. Komatsu T, Kunugita F, Ozawa M, et al: Relationship between Impairment of the Vascular Endothelial Function and the CHA2DS2-VASc Score in Patients with Sinus Rhythm and Non-valvular Atrial Fibrillation. Intern Med. 2018;57(15):2131-2139.
5. Deniz A, Sahiner L, Aytemir K, et al: Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J 2012; 19:487–493.
6. Daubert JC, Pavin D, Jauvert G, et al: Intra and interatrial conduction delay: implications for cardiac pacing. Pacing Clin Electrophysiol 2004; 27:507
7. Perk J, De Backer G, Gohlke H, et al: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33:1635–701
8. Cheitlin MD, Armstrong WF, Aurigemma GP, et al: ACC/AHA/ASE 2003 guideline up- date for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108: 1146–1162.
9. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease: a review. Eur Heart J 2004; 25:1776 – 87
10. Kosch M, Hausberg M, Vormbrock K, et al: Studies on flow- mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens. 2000; 13:759–64
11. Gennari C, Nami R, Gonnelli S. Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab. 1995; 21:77–81.
12. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery. 2001; 130:986–90.
13. Kepez A, Yasar M, Sunbul M, et al: Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy? Wien Klin Wochenschr. 2017 May;129(9-10):329-336.
14. Ozdemir D, Kalkan GY, Bayram NA, et al: Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism. Endocrine. 47: 609-17 (2014).
15. Ekmekci A, Abaci N, Colak Ozbey N, et al: Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J. Endocrinol. Invest. 32: 611-16 (2009).
16. Lind L, Ljunghall S. Serum calcium and the ECG in patients with primary hyperparathyroidism. Journal of Electrocardiology. 27: 99–103 (1994).
17. Surawicz B. Role of electrolytes in etiology and management of cardiac arrhythmias. Prog Cardiovasc Dis. 8:364–86 (1966).
18. Cui QQ, Zhang W, Wang H, et al: Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol 2008; 31:74.
19. Roshanali F, Mandegar MH, Yousefnia MA, et al: Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis. Interact Cardiovasc Thorac Surg 2009; 8:421–425.
20. Bakirci EM, Demirtas L, Degirmenci H, et al: Relationship of the total atrial conduction time to subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes mellitus. Clinics (Sao Paulo). 2015;70(2):73-80.
21. Ermiş N, Açıkgöz N, Yaşar E, et al: Evaluation of atrial conduction time by P-wave dispersion and tissue Doppler echocardiography in prehypertensive patients. Turk Kardiyol Dern Ars 2010; 38:525–530.
22. Ozer N, Yavuz B, Can I, et al: Doppler tissue evaluation of intra-atrial and interatrial elec- tromechanical delay and comparison with P- wave dispersion in patients with mitral stenosis. J Am Soc Echocardiogr 2005;18: 945–948.
23. Calapkorur B, Kelesoglu B, Sarli B, et al: Atrial Electromechanical Delay Is Impaired in Patients with Psoriasis. Med Princ Pract 2015;24:30–35.
24. Efe TH, Cimen T, Ertem AG et al: Atrial Electromechanical Properties in Inflammatory Bowel Disease. Echocardiography 2016 Sep;33(9):1309-16
25. Deniz A, Yavuz B, Aytemir K, et al: Intra- left atrial mechanical delay detected by tissue Doppler echocardiography can be a useful marker for paroxysmal atrial fibrillation. Echocardiography 2009; 26:779–784.
26. Hove-Madsen L, Llach A, Bayes-Genis A, Roura S, Rodriguez Font E, Aris A, Cinca J. Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation. 2004; 110:1358 –1363
27. Voigt N, Li N, Wang Q, Wang W, Trafford AW, Abu-Taha I, Sun Q, Wieland T, Ravens U, Nattel S et al. Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+- Ca2+ exchanger function underlie delayed after depolarizations in patients with chronic atrial fibrillation. Circulation 2012 125 2059–2070. (doi: 10.1161/ CIRCULATION AHA.111.067306)
28. Rosenqvist M, Nordenström J, Andersson M, Edhag OK. Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism. Clin Endocrinol (Oxf). 1992; 37:29–33.
29. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Famebo LO. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg. 1996; 162:171–6.
30. Curione M, Letizia C, Amato S et all. Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol. 2007 Oct 1;121(2):200-2
31. Ogino K, Burkhoff D, Bilezikian JP. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 1995; 136:3024–30.
32. Cheng S-P, Liu C-L, Liu T-P, Hsu Y-C, Lee J-J. Association between parathyroid hormone levels and inflammatory markers among US adults. Mediat Inflamm 2014;2014:1-8.
33. Shor R, Tilis Y, Boaz M, Matas Z, Fux A et al. Serum parathyroid hormone-related protein levels before and after paroxysmal atrial fibrillation. American Journal Emergency Medicine 2008; 26:361-363. doi: 10.1016/j.ajem.2007.08.005.
34. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH et al. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circulation Heart Failure 2014; 7:732-739. doi: 10.1161/CIRC HEART FAILURE.114.001272
35. Rienstra M, Lubitz SA, Zhang ML, Cooper RR, Ellinor PT. Elevation of parathyroid hormone levels in atrial fibrillation. J Am Coll Cardiol. 2011;57(25):2542-2543. doi:10.1016/j.jacc.2011.01.041
36. Lee KH, Shin MH, Park HW, Cho JG, Kweon SS et al. Association between Serum Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation: the Dong-gu Study. Korean Circulation Journal. 2018;48(2):159-167. doi: 10.4070/kcj.2017.0187.
37. Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V, Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring. Eur. J. Endocrinol. 179(2):117-124 (2018)